Professionals and Partners
Go to Professionals and Partners

Professionals and Partners

Our core expertise is the development and manufacturing of high-quality generic and in-licensed medicines with a proven cost-effectiveness ratio.

Individuals and Families
Go to Individuals and Families

Individuals and Families

We believe in improving the life of individuals and families by using the best current research. We use our resources to drive future scientific and manufacturing development for the constant betterment of therapies.

Home

Tchaikapharma High Quality Medicines Inc. is devoted to providing individuals and families with a wide range of affordable contemporary high-quality pharmaceuticals fighting socially significant diseases.

  • November 26, 2021

    Tchaikapharma High Quality Medicines obtained marketing authorisations for the Republic of Kosovo for the medicinal products Bilamcar 8 mg/5 mg; 16 mg/5 mg hard capsules and Ceftriaxon-Tchaikapharma 1 g; 2 g powder for solution for injection/infusion. The first deliveries are planned for early 2022.   Thus, the number of registered products of the company in […]

  • November 22, 2021

    The latest medicinal products to receive Marketing Authorization from the BDA and expand Tchaikapharma’s rich and diverse portfolio are:   – Tamaira Plus 5 mg/5 mg/12.5 mg; 5 mg/5 mg/25 mg; 10 mg/5 mg/25 mg hard capsules (with APIs ramipril, amlodipine and hydrochlorothiazide).   The medicinal product is indicated for the treatment of high blood […]

  • July 7, 2021

    The first half of this year did not bring much of a stir in stock trading as a consequence of both the development of the pandemic and the slow recovery of the economy.   However, at the end of June this year, the Bulgarian Stock Exchange had a public company with a market capitalization of […]

  • May 21, 2021

    Tchaikapharma Highquality Medicines, a flagship company on the Bulgarian pharma market, started trading shares on the Bulgarian Stock Exchange (BSE) on 21 May 2015. On today’s date exactly 6 years ago, the initial offering price per share was BGN 3.59, and on 21 May 2021 – BGN 14.10. This represents a growth of 292.757% over […]

  • February 23, 2021

    SOFIA (Bulgaria), February 23 (SeeNews) – Bulgarian drug maker Tchaikapharma High Quality Medicines [BUL:7TH] said that its shareholders have approved its plan to borrow up to 14 million euro ($17.2 million) in order to finance the construction of a new production plant just outside Sofia.   The proposal was supported by all shareholders present at […]